PPAR-COMBO With Sulfonylurea

NCT00162175 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

534

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolics Diabetes Nos

Interventions

DRUG: Muraglitazar

Sponsor

Bristol-Myers Squibb